Strategic Business Development & Licensing
Biocomm2 was established to provide strategic input and assistance to biotech and pharmaceutical companies. Our principals have significant business experience covering drug discovery, biopharmaceuticals, diagnostics and medical devices.
Biocomm2 principals have worked with many biotech companies in Australia, New Zealand, Japan, the UK, Ireland, Netherlands and the US, having completed deals over the last five years worth >US$200 million.
Biocomm2 has extensive direct coverage of the biotechnology and health care sectors in Australia, New Zealand and Japan. Biocomm2 is currently expanding its European and Japanese services into veterinary medicine, biomedical devices and diagnostics equipment, while consolidating its position in Asian-Pacific markets.
News February 2016: Biocomm2 will be attending Bio2016 in San Francisco.